In-vitro Fertilization (IVF) Market Analysis

In-vitro Fertilization Market Analysis

To get key market trends

  Download Free Sample

Based on product, the market is segmented into equipment, reagents & media, and accessories. The equipment segment, which dominated the market in 2023 and accounted for USD 9.4 billion, is further bifurcated into microscope, imaging system, sperm analyzer system, ovum aspiration pump, micromanipulator system, incubator, gas analyzer, cryosystem, laser system, sperm separation system, cabinet, anti-vibration table, witness system, and other equipment.
 

• IVF equipment is typically expensive, contributing to a larger market share. Items including incubators, micromanipulators, cryopreservation units, and imaging systems require significant investment, and the cost of maintaining and upgrading these machines adds to the overall expenditure.
   
• Moreover, compliance with strict regulatory standards for fertility clinics and laboratories necessitates the use of high-quality equipment. Regulations often mandate specific types of equipment to ensure safety, accuracy, and reliability in IVF procedures, further increasing the demand for compliant and high-performance equipment.
   

Based on the type of cycle, the IVF market is segmented into fresh non-donors, frozen non-donors, frozen donors, and fresh donors. The fresh non-donors segment dominated the market in 2023, with a market share of 48.1%.
 

• The success rate is higher in the case of fresh non-donor cycles. In this type of cycle, a woman’s own eggs are used immediately after retrieval, resulting in higher success rates compared to other types of cycles. This is because the eggs are fresh and have not been subjected to the freezing and thawing process, which can potentially damage them or reduce their quality.
   
• Fresh non-donor cycles tend to be less expensive than cycles involving donor eggs. The cost of acquiring and compensating an egg donor, along with additional legal and medical processes, makes donor cycles more expensive, thereby increasing the preference for fresh non-donor cycles.
   
• In many fertility clinics, fresh non-donor cycles are the standard initial approach for patients undergoing IVF, particularly for those who have not been diagnosed with severe ovarian issues. Clinics often recommend this as the first option before considering alternatives like frozen embryo transfers (FET) or donor eggs. These factors contribute to overall market growth.
   

Based on procedure, the in-vitro fertilization market is segmented into conventional IVF, IVF with intracytoplasmic sperm injection (ICSI), minimal IVF, IVF with donor eggs, and other procedures. The conventional IVF segment dominated the market in 2023 and is expected to witness growth at a CAGR of 5.4%.
 

• Conventional IVF typically has higher success rates compared to other forms of IVF, such as natural cycle IVF or mini-IVF. This is because conventional IVF involves stimulating the ovaries to produce multiple eggs, increasing the chances of successful fertilization and embryo development.
   
• Conventional IVF can be effective for a wide range of fertility issues, including male factor infertility, tubal blockages, and unexplained infertility, making it a versatile option.
   
• Conventional IVF is a well-established and widely studied procedure with decades of clinical experience, making it a trusted and reliable option for many fertility specialists and patients. These factors contribute to the segment’s growth.
   

Based on end-use, the in-vitro fertilization market is bifurcated into fertility clinics and IVF centers, hospitals & surgical centers, research institutes, and cryobanks. The fertility clinics and IVF centers segment is anticipated to reach USD 18.7 billion by 2032.
 

• Fertility clinics and IVF centers are highly preferred by patients due to the presence of experts, including reproductive endocrinologists, embryologists, and fertility nurses, who are highly trained in IVF and other fertility treatments at these settings.
   
• Fertility clinics are equipped with state-of-the-art technology specifically designed for assisted reproductive procedures, which might not be available in general hospitals.
   
• Fertility clinics may offer more flexible payment options and packages tailored to fertility treatments, which can be more cost-effective for patients compared to the broader services offered by hospitals. These factors result in a high adoption rate.
   

North America dominated the global in-vitro fertilization market in 2023 with a revenue of USD 6.2 billion and is anticipated to reach USD 9.8 billion by 2032.
 

• North America is known for its innovative medical technology and innovation. Fertility clinics in this region have access to the latest advancements in reproductive medicine, making IVF a widely available and effective option.
   
• Many couples in North America face fertility challenges due to factors such as delayed childbearing, lifestyle choices, and underlying health conditions. As more individuals and couples delay having children for career or personal reasons, the demand for fertility treatments like IVF has increased.
   
• In some parts of North America, particularly in certain states and provinces, insurance coverage for IVF is available, making it more accessible to a broader population. Additionally, various financing options and payment plans offered by fertility clinics help make IVF treatments more affordable.
   

The U.S. in-vitro fertilization market was valued at USD 5.9 billion in 2023.
 

• IVF is one of the most common forms of assisted reproductive technology (ART) used in the U.S. Due to factors like delayed childbearing, increased awareness, and the rising prevalence of infertility issues, the demand for IVF has grown significantly.
   
• The U.S. is home to some of the most advanced fertility clinics in the world, offering innovative technologies such as preimplantation genetic testing (PGT), egg freezing, and embryo selection.
   
• Insurance coverage for IVF varies widely across the U.S. Some states mandate insurance coverage for fertility treatments, which positively affects market growth.
   

Germany is anticipated to witness robust growth in the global in-vitro fertilization market.
 

• Germany has seen a trend of couples delaying childbearing due to career, education, or personal reasons. As women age, fertility naturally declines, leading to a higher demand for IVF treatments.
   
• Factors such as stress, unhealthy diets, smoking, and environmental pollutants contribute to rising infertility rates, which in turn drive the demand for assisted reproductive technologies (ART) like IVF.
   
• Additionally, Germany is known for its advanced healthcare system and technological innovation. The development and adoption of new reproductive technologies, such as preimplantation genetic testing (PGT), time-lapse imaging of embryos, and improved cryopreservation techniques, have made IVF more effective and attractive to prospective parents.
   

The Asia Pacific region is anticipated to witness high growth in the in-vitro fertilization market, growing at a CAGR of 7% over the analysis years.
 

• Similar to global trends, couples in the Asia-Pacific region are increasingly delaying childbearing due to career, education, and personal reasons. This delay, particularly among women, contributes to higher infertility rates and drives the demand for IVF services.
   
• The Asia-Pacific region has become a hub for medical tourism, with countries like India, Thailand, Malaysia, and Singapore attracting international patients seeking affordable and high-quality IVF treatments. Lower costs, coupled with advanced medical care, make these countries popular destinations for fertility treatment.
   
• Japan and South Korea have aging populations and declining birth rates, leading to strong government support for IVF and other fertility treatments.